Patients treated for advanced neuroendocrine tumors (NETs) are at risk of disease progression after existing treatments, and the current options are often dependent on particular disease factors that ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Tumor DNA in the Blood Can Predict Lung Cancer Outcome Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts ...

Teddi Mellencamp has shared a hopeful update in her cancer journey after revealing earlier this year that melanoma had spread ...

Veteran actress Sharmila Tagore's early-stage lung cancer diagnosis has brought attention to zero-stage lung cancer, also known as carcinoma in situ. Discovered during a routine check, this pre ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

Current experimental treatment regimens include combinations of cytotoxic chemotherapy, immune checkpoint antibodies, and therapeutics directed at molecules expressed preferentially in small cell lung ...